BioNexus Gene Lab Statistics
Total Valuation
BGLC has a market cap or net worth of $10.37 million. The enterprise value is $7.52 million.
Important Dates
The last earnings date was Monday, August 18, 2025, after market close.
Earnings Date | Aug 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BGLC has 1.80 million shares outstanding. The number of shares has increased by 2.84% in one year.
Current Share Class | 1.80M |
Shares Outstanding | 1.80M |
Shares Change (YoY) | +2.84% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 36.95% |
Owned by Institutions (%) | 0.53% |
Float | 1.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.09 |
Forward PS | n/a |
PB Ratio | 1.38 |
P/TBV Ratio | 1.38 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.79 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.03.
Current Ratio | 3.63 |
Quick Ratio | 2.94 |
Debt / Equity | 0.03 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -142.25 |
Financial Efficiency
Return on equity (ROE) is -34.37% and return on invested capital (ROIC) is -21.85%.
Return on Equity (ROE) | -34.37% |
Return on Assets (ROA) | -18.85% |
Return on Invested Capital (ROIC) | -21.85% |
Return on Capital Employed (ROCE) | -40.45% |
Revenue Per Employee | $318,385 |
Profits Per Employee | -$97,773 |
Employee Count | 30 |
Asset Turnover | 0.93 |
Inventory Turnover | 7.30 |
Taxes
Income Tax | -72,158 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.11% in the last 52 weeks. The beta is 1.90, so BGLC's price volatility has been higher than the market average.
Beta (5Y) | 1.90 |
52-Week Price Change | +28.11% |
50-Day Moving Average | 5.22 |
200-Day Moving Average | 3.65 |
Relative Strength Index (RSI) | 54.16 |
Average Volume (20 Days) | 87,562 |
Short Selling Information
The latest short interest is 54,041, so 3.01% of the outstanding shares have been sold short.
Short Interest | 54,041 |
Short Previous Month | 703,725 |
Short % of Shares Out | 3.01% |
Short % of Float | 4.77% |
Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, BGLC had revenue of $9.55 million and -$2.93 million in losses. Loss per share was -$1.63.
Revenue | 9.55M |
Gross Profit | 1.35M |
Operating Income | -3.10M |
Pretax Income | -2.64M |
Net Income | -2.93M |
EBITDA | -2.98M |
EBIT | -3.10M |
Loss Per Share | -$1.63 |
Full Income Statement Balance Sheet
The company has $3.06 million in cash and $212,945 in debt, giving a net cash position of $2.85 million or $1.58 per share.
Cash & Cash Equivalents | 3.06M |
Total Debt | 212,945 |
Net Cash | 2.85M |
Net Cash Per Share | $1.58 |
Equity (Book Value) | 7.52M |
Book Value Per Share | 4.19 |
Working Capital | 4.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.09 million and capital expenditures -$233,722, giving a free cash flow of -$3.32 million.
Operating Cash Flow | -3.09M |
Capital Expenditures | -233,722 |
Free Cash Flow | -3.32M |
FCF Per Share | -$1.85 |
Full Cash Flow Statement Margins
Gross margin is 14.11%, with operating and profit margins of -32.46% and -30.71%.
Gross Margin | 14.11% |
Operating Margin | -32.46% |
Pretax Margin | -31.46% |
Profit Margin | -30.71% |
EBITDA Margin | -31.22% |
EBIT Margin | -32.46% |
FCF Margin | n/a |
Dividends & Yields
BGLC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.84% |
Shareholder Yield | -2.84% |
Earnings Yield | -28.30% |
FCF Yield | -32.03% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on April 7, 2025. It was a reverse split with a ratio of 1:10.
Last Split Date | Apr 7, 2025 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
BGLC has an Altman Z-Score of 1.83 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.83 |
Piotroski F-Score | 1 |